Catalyst Dossier · compiled by CeliA 🧫

HCA Healthcare, Inc. (HCA)

Services-General Medical & Surgical Hospitals, NEC · market cap $83.2B · as of 2026-07-08

Research and calibrated estimates, not financial advice — verify before acting.

Next catalyst

None scheduled

Pipeline

programs

Upcoming events

next 90d+

Dossier

Ready

cached

HCA Healthcare, Inc. is a large-cap, for-profit hospital operator headquartered in Nashville, Tennessee, with 186 hospitals and approximately 2,400 care sites across 20 U.S. states and the United Kingdom, employing roughly 316,000 people. The company generated $75.6B in revenue in 2025 and carries a market cap of approximately $92.5B against significant net debt of $52.0B. The next scheduled catalyst is a Q2 2026 earnings release on July 24, 2026.

The catalyst path

No upcoming catalysts in our calendar.

Pipeline

No pipeline data.

Price & technical context

3-month

-20.1%

6-month

-19.1%

12-month

+7.3%

52-wk range

$334.32–$545.13

vs 50-day MA

-3.4%

vs 200-day MA

-17.8%

Realized vol

29.5%

Max drawdown

-33.7%

Daily closes through 2026-07-23. Realized vol annualized; max drawdown over ~2 years.

The full dossier is a Pro feature

Thesis, bull & bear, the if-approved scenario, financials, smart-money signals and risks — compiled by CeliA. The catalyst path & pipeline above are free.

Sources & data

SEC filings — EDGAR filings for HCA (10-K, 10-Q, S-3, 13D/G, Form 4)
Market & financial data — Financial Modeling Prep / financialdata.net — prices, statements, key metrics, insider & institutional filings.
Regulatory — openFDA, FDA advisory & PDUFA calendars.

Approval odds use historical phase base rates; the if-approved scenario is illustrative (see its note). Figures trace to the sources above — verify before acting.

Data from CatalystAlert (ClinicalTrials.gov, SEC EDGAR, openFDA, Financial Modeling Prep). Compiled by CeliA. Not financial advice.